Skip to main content
. 2011 Apr 27;24(2):103–109. doi: 10.1111/j.1708-8240.2011.00417.x

Table 3.

Days until healed

Median Mean (SD)
Viroxyn and Abreva users

 Control 11.0 11.5 (3.8)*

 Abreva 7.0 7.6 (2.2)

 Viroxyn 3.0 4.0 (2.0)

N = 180

Viroxyn only users

 Control (untreated cold sore) 10.0 11.1 (3.3)*

 Viroxyn 3.0 4.0 (2.5)

N = 58

Definition: loss of hard scab and return to intact skin.

*

Control versus Abreva (t-test; p < 0.001).

Control versus Viroxyn (t-test; p < 0.001).

Viroxyn versus Abreva (t-test; p < 0.001).